These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37769147)

  • 1. Hyaluronic Acid-Conjugated Fluorescent Probe-Shielded Polydopamine Nanomedicines for Targeted Imaging and Chemotherapy of Bladder Cancer.
    Qiu H; Wang J; Zhi Y; Yan B; Huang Y; Li J; Shen C; Dai L; Fang Q; Shi C; Li W
    ACS Appl Mater Interfaces; 2023 Oct; 15(40):46668-46680. PubMed ID: 37769147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer.
    Zhu G; Wang K; Qin H; Zhao X; Chen W; Xu L; Cao W; Guo H
    J Nanobiotechnology; 2020 Sep; 18(1):124. PubMed ID: 32887622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer.
    Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H
    Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronic acid-modified, IR780-conjugated and doxorubicin-loaded reduced graphene oxide for targeted cancer chemo/photothermal/photodynamic therapy.
    Dash BS; Lu YJ; Pejrprim P; Lan YH; Chen JP
    Biomater Adv; 2022 May; 136():212764. PubMed ID: 35929292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photosensitizer-Conjugated Hyaluronic Acid-Shielded Polydopamine Nanoparticles for Targeted Photomediated Tumor Therapy.
    Han J; Park W; Park SJ; Na K
    ACS Appl Mater Interfaces; 2016 Mar; 8(12):7739-47. PubMed ID: 26965036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
    Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
    Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted hollow pollen silica nanoparticles for enhanced intravesical therapy of bladder cancer.
    Wang L; Qi F; Bi L; Yan J; Han X; Wang Y; Song P; Wang Y; Zhang H
    Biomater Sci; 2023 Jul; 11(14):4948-4959. PubMed ID: 37314787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
    Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
    Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44-Targeted Photoactivatable Polymeric Nanosystem with On-Demand Drug Release as a "Photoactivatable Bomb" for Combined Photodynamic Therapy-Chemotherapy of Cancer.
    Lan JS; Zeng RF; Li Z; Wu Y; Liu L; Chen LX; Liu Y; He YT; Zhang T; Ding Y
    ACS Appl Mater Interfaces; 2023 Jul; 15(29):34554-34569. PubMed ID: 37462246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
    Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using chitosan-stabilized, hyaluronic acid-modified selenium nanoparticles to deliver CD44-targeted
    Shahidi M; Abazari O; Dayati P; Reza JZ; Modarressi MH; Tofighi D; Haghiralsadat BF; Oroojalian F
    Nanomedicine (Lond); 2023 Feb; 18(3):259-277. PubMed ID: 37125618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed Lanthanide Oxide Nanoparticles Coated with Alginate-Polydopamine as Multifunctional Nanovehicles for Dual Modality: Targeted Imaging and Chemotherapy.
    Addisu KD; Hsu WH; Hailemeskel BZ; Andrgie AT; Chou HY; Yuh CH; Lai JY; Tsai HC
    ACS Biomater Sci Eng; 2019 Oct; 5(10):5453-5469. PubMed ID: 33464065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy.
    Liu Y; Qiao L; Zhang S; Wan G; Chen B; Zhou P; Zhang N; Wang Y
    Acta Biomater; 2018 Jan; 66():310-324. PubMed ID: 29129789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted co-delivery of a photosensitizer and an antisense oligonucleotide based on an activatable hyaluronic acid nanosystem with endogenous oxygen generation for enhanced photodynamic therapy of hypoxic tumors.
    Wu Y; Ding L; Zheng C; Li H; Wu M; Sun Y; Liu X; Zhang X; Zeng Y
    Acta Biomater; 2022 Nov; 153():419-430. PubMed ID: 36115655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy.
    Wei Y; Gao L; Wang L; Shi L; Wei E; Zhou B; Zhou L; Ge B
    Drug Deliv; 2017 Nov; 24(1):681-691. PubMed ID: 28414557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-targeting pH/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA.
    Yuan Y; Liu J; Yu X; Liu X; Cheng Y; Zhou C; Li M; Shi L; Deng Y; Liu H; Wang G; Wang L; Wang Z
    Acta Biomater; 2021 Nov; 135():556-566. PubMed ID: 34496281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Floating poly(lactic-co-glycolic acid)-based controlled-release drug delivery system for intravesical instillation.
    Fu K; Zhou Y; Hou J; Shi T; Ni J; Li X; Zhang H
    J Int Med Res; 2023 Apr; 51(4):3000605231162065. PubMed ID: 37038914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.